biotech
biotech Articles
Here, 24/7 Wall St. has included a calendar of a few of companies to watch for in the coming week and the rest of June.
Published:
Last Updated:
Heron Therapeutics shares made a massive gain on Thursday after the company announced a few key developments.
Published:
Last Updated:
For many drug developers, Parkinson’s disease is a tricky disease to treat. However, developing a treatment ultimately could yield a huge reward as there are currently no therapies that effectively...
Published:
Last Updated:
Sarepta Therapeutics shares skyrocketed on Tuesday after the firm presented positive preliminary results from its midstage Duchenne muscular dystrophy trial.
Published:
Last Updated:
Foundation Medicine shares saw a sizable jump early on Tuesday after the company announced that Roche would be acquiring all of the outstanding shares.
Published:
Last Updated:
Clinical-stage immuno-oncology company Forty Seven intends to price more than 6 million shares so that the entire offering is valued up to more than $123 million.
Published:
Last Updated:
PTC Therapeutics watched its shares make a massive gain early on Monday after the firm presented updated preliminary results from its study investigating risdiplam in babies with spinal muscular...
Published:
Last Updated:
Solid Biosciences watched its shares surge to kick off the week after the FDA lifted the clinical hold on its treatment for Duchenne muscular dystrophy.
Published:
Last Updated:
Neon Therapeutics filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering. The company intends to price its 6.25 million shares in the...
Published:
Last Updated:
Affimed N.V. (NASDAQ: AFMD) shares dropped sharply early on Friday after the firm released new results from its early stage trial with Keytruda. The firm presented new interim data from the Phase 1b...
Published:
Last Updated:
Nightstar Therapeutics PLC (NASDAQ: NITE) shares saw a massive gain on Thursday after the firm announced a crucial decision from the U.S. Food and Drug Administration (FDA). Essentially, the agency...
Published:
Last Updated:
Sage Therapeutics, Inc. (NASDAQ: SAGE) shares made a handy gain on Tuesday after the firm announced its expedited development plan for SAGE-217 following a Breakthrough Therapy meeting with the U.S....
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest moves...
Published:
Last Updated:
Shares of CRISPR Therapeutics tumbled after a report was released that gene-edited cells might cause cancer. The implications of this study could be catastrophic for the company seeing as CRISPR is...
Published:
Last Updated:
Here 24/7 Wall St. has included a calendar of a few of companies to watch for in the coming week and the rest of June.
Published:
Last Updated: